Additional information: device available for evaluation, returned to manufacturer on 12/11/2017.Device evaluation: the 1mtec30 cartridge was returned to the manufacturing site for evaluation.Visual inspection was performed using microscope magnification which showed no defects on the returned cartridge such as missing part, broken or cracks that could lead to the reported issue.Only residues of dry viscoelastic at the cartridge tip, tube, and loading zone were observed.No plastic particles at any section of the cartridge were detected during sample evaluation.The reported plastic particle observed by the surgeon was not returned for investigation.The condition observed in the returned cartridge is consistent with unit that has been handled and prepared for surgical use.The customer's reported complaint was not verified.The sample was sent for fourier transfer infrared (ftir) analysis.Ftir spectra analysis indicates the presence of sodium hyaluronate on the interior surface of the cartridge unit in question.Per the instruction for use (dfu) sodium hyaluronate is related to viscoelastics (ophthalmic viscosurgical devices (ovds).And the ovds products is consistent with sodium hyaluronate.Therefore, there is no evidence to suggest that the reported 1mtec30 cartridge was affected by the manufacturing process.Manufacturing records review: the manufacturing records for the cartridge were reviewed.The product was manufactured and released according to specification.Labeling review: the directions for use (dfu) was reviewed.The dfu adequately provides instructions and precautions along with warnings for the proper use and handling of the device.As a result of the investigation, there is no indication of a product quality deficiency and the reported issue could not be verified.All pertinent information available to abbott medical optics has been submitted.
|